- Home
- ORGO vs VVR Comparison
ORGO vs VVR Comparison
Compare ORGO & VVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORGO
- VVR
- Stock Information
- Founded
- ORGO 1985
- VVR 1998
- Country
- ORGO United States
- VVR United States
- Employees
- ORGO N/A
- VVR N/A
- Industry
- ORGO Biotechnology: Pharmaceutical Preparations
- VVR Trusts Except Educational Religious and Charitable
- Sector
- ORGO Health Care
- VVR Finance
- Exchange
- ORGO Nasdaq
- VVR Nasdaq
- Market Cap
- ORGO 465.6M
- VVR 544.1M
- IPO Year
- ORGO N/A
- VVR N/A
- Fundamental
- Price
- ORGO $4.32
- VVR $3.81
- Analyst Decision
- ORGO Hold
- VVR
- Analyst Count
- ORGO 1
- VVR 0
- Target Price
- ORGO $6.00
- VVR N/A
- AVG Volume (30 Days)
- ORGO 918.2K
- VVR 692.2K
- Earning Date
- ORGO 08-07-2025
- VVR 01-01-0001
- Dividend Yield
- ORGO N/A
- VVR 11.38%
- EPS Growth
- ORGO N/A
- VVR N/A
- EPS
- ORGO N/A
- VVR N/A
- Revenue
- ORGO $458,760,000.00
- VVR N/A
- Revenue This Year
- ORGO $1.10
- VVR N/A
- Revenue Next Year
- ORGO $9.93
- VVR N/A
- P/E Ratio
- ORGO N/A
- VVR N/A
- Revenue Growth
- ORGO 5.35
- VVR N/A
- 52 Week Low
- ORGO $2.28
- VVR $3.55
- 52 Week High
- ORGO $6.71
- VVR $4.38
- Technical
- Relative Strength Index (RSI)
- ORGO 68.34
- VVR 60.18
- Support Level
- ORGO $3.59
- VVR $3.79
- Resistance Level
- ORGO $4.70
- VVR $3.83
- Average True Range (ATR)
- ORGO 0.23
- VVR 0.04
- MACD
- ORGO 0.12
- VVR 0.01
- Stochastic Oscillator
- ORGO 81.15
- VVR 95.22
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.
About VVR Invesco Senior Income Trust (DE)
Invesco Senior Income Trust is a diversified, closed-end management investment company. The investment objective of the company is to provide a high level of current income, consistent with the preservation of capital. The company invests in a portfolio of interests in floating or variable senior loans to corporations, partnerships, and other entities which operate in a variety of industries and geographic regions.